Join the uMotif team at SCOPE 2022
We are thrilled to be launching our brand new TrialMotif™ Platform during SCOPE 2022!
7th – 10th February 2022, Florida and Virtual
Come and visit us at booth #928 to find out more
The uMotif team will be attending SCOPE 2022 and we are thrilled to announce that we will be launching an exciting new product at the conference.
Don’t forget to come and see the team at booth #928 to find out about our brand new TrialMotif app – the next generation eCOA solution, designed for the most simple to the most complex trials.
The theme of SCOPE 2022 is all about the importance of collaboration and innovation in clinical research, and our team will be on hand to discuss how our new, patient-centric TrialMotif™ platform, built in collaboration with users, is at the forefront of patient engagement innovation, and can play a crucial role in the success of decentralized research studies.
Launching at SCOPE 2022:
TrialMotif – Engaged Patients. Better Trials
At uMotif, we believe that patient engagement is more than sending patient reminders. Our mission is to improve the patient experience whilst allowing them to contribute their data during the life cycle of the trial, supporting the drug approval process.
Our patient-centric platform, powering site-based to fully decentralized clinical, real-world, and post-marketing research, has been designed with patients, for patients, to help reduce the burden of contributing to research. Our technology has been tried and tested for over 10 years and is proven to engage up to 91%* of research patients.
TrialMotif is the next generation eCOA solution, designed for the most simple to the most complex of trials.
As clinical trial technology experts, we understand the challenges that Sponsors and Clinical Research Organisations face, particularly when it comes to patient engagement. Over the last year, the uMotif team has been working hard to combine our unique human-centred design methodology, with the brand new TrialMotif app.
Our flexible new platform enables sponsors to continuously engage and capture every patient (data) experience via our beautifully designed technology, from the start and throughout the life cycle of the research process. Out technology is fully configurable to fit the protocol and the patient and can meet the requirements of any study, large or small, site based, or virtual.
Our philosophy is simple. Engaged patients are happy patients. And happy patients stay the course of the study and contribute their data until the end to support sponsors’ goals and capture better patient data.
We are extremely excited to be able to present our brand new TrialMotif app to you at SCOPE 2022.
Be sure to visit our team at booth #928 where one of our team of clinical trial experts will be on hand to give you a demo, or contact one of our team below to book a demonstration appointment (either face to face, or online).
For all UK and Europe enquiries, contact:
Gavin Birchnall, Senior Director Digital Patient Solutions
For all US enquiries, contact:
Don Butler, Chief Revenue Officer
Daily prizes to be won!!
The team look forward to welcoming you to our stand and showcasing our new TrialMotif platform. To celebrate the launch of our new platform at the conference, we have some fanstic daily giveaways! If you are heading out to Florida, be sure to swing by our stand for your chance to win some amazing prizes!
Cathy Molohan, Patient Story
Cathy, a Parkinson’s Patient, on using the uMotif app to track symptomsView video
Katie Druce, Researcher Story
Katie Druce, Patient and Public Engagement Lead as the Centre for Epidemiology Versus Arthritis, discusses two virtual research projects powered by the uMotif platform – QUASAR and GIRAFView video
Will Dixon, Researcher Story
Cloudy with a Chance of Pain – Will Dixon, Professor of Digital Epidemiology at the University of Manchester, used uMotif technology to study the link between weather and painView video
*91% of patients engaged during QUASAR sleep study